Observational studyCancer medicine2025

Real-Life Cohort of Patients With Resected High-Risk Melanoma Treated by Adjuvant Anti-PD1 Therapy.

Liza Benzoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.